期刊文献+

CB-Aβ抗体偶联物抑制痴呆小鼠脑内Aβ纤维斑块形成 被引量:1

The inhibition of brain amyloid Aβ burden with cholera toxin B subunit and anti-Aβ monoclonal antibody conjugate in senile dementia mice
下载PDF
导出
摘要 目的研究CB-Aβ多肽抗体(IgG)是否能高效的进入痴呆小鼠脑内,发挥抑制Aβ纤维斑块形成的作用。方法用改良过碘酸钠法制备CB-IgG偶联物;鼻腔给予C57小鼠CB-IgG后用间接ELISA法测定脑内抗体量;给予C57小鼠抗体3 h后用间接ELISA测血清和脑区抗体量;5XFAD小鼠分为CB-IgG IN组,IgG IN组,IgG IV组,阳性对照组和阴性对照组,抗体干预14周后,双抗夹心ELISA检测脑内Aβ水平,免疫组化染色观察Aβ沉积和老年斑。结果鼻腔给予CB-IgG 0.3 h时在脑内即可检测到Aβ抗体的存在(P<0.05),3 h后达峰值(P<0.01);抗体给予3 h后,CB-IgG IN组海马区的抗体量高于IgG IN组和IgG IV组10倍以上(P<0.05),IgG IV组与IgG IN组脑内的抗体量接近;CB-IgG IN组小鼠脑内Aβ水平比阳性对照组显著降低(P<0.05);CB-IgG IN组海马和皮层区的老年斑面积与阳性对照组相比分别减少了80%以上(P<0.05)。结论鼻腔给予CB-IgG的方式,在提高抗体入脑量、抑制痴呆鼠脑内Aβ纤维斑块形成等方面均优于其他途径和措施。 Objective To study the inhibition effect of anti-Aβ monoclonal antibody(IgG) conjugated with cholera toxin B subnnit(CB) on brain Aβ burden in senile dementia mice. Methods IgG was conjugated with CB by im- proved sodium metaperiodate method. CB-IgG amount that accessed into the brain of mice was measured by indirect ELISA, which was also employed to measure IgG amount of brain different regions and blood sample after 3 hours of IgG administration. Transgenic mice were used to study the role of CB-IgG in inhibition of Aβ burden compared with IgG IN group, IgG IV group and wild type mice, after 14 weeks of IgG administration, AI3 level of brain was assessed by sandwich ELISA and Aβ deposits and senile plaques were observed by immunostaining. Results The trace of IgG in brain could be detected after 0. 3 hours of CB-IgG intranasal administration ( P 〈 0.05 ) and IgG amount achieved to peak at 3 hours ( P 〈 0. 01 ) when the amount of IgG in hippocampus was 10-fold higher in CB-IgG group than IgG IN group or IgG IV group (P 〈 0.05) ,and IgG quantity in brain was similar between IgGIN aud IgG IV group. Compared with positive control group, the duced (P〈0.05), percent Aβ load in hippocampus and cortex ( P 〈0. 05 ). Conclusions CB-IgG heatment via intranasal was a promising approach that can effectively penetrate into brain,decrease Aβ deposits and senile plaques.
出处 《基础医学与临床》 CSCD 北大核心 2013年第7期834-839,共6页 Basic and Clinical Medicine
基金 国家"十二五"科技重大专项"重大新药创制"项目(2012ZX09103301-051)
关键词 霍乱毒素B亚单位 Aβ多肽抗体 5XFAD小鼠 阿尔茨海默病 choleratoxin B subunil anti-amyloid β peptide antibodies 5XFAD mice Alzheimcr's disease
  • 相关文献

参考文献13

  • 1Wisniewski T, Konietzko U. Amyloid- immunisation for Alzheimer disease[ J]. Lancet Neuro1,2008 ,7 :805 - 811.
  • 2Morgan D. hnmunotherapy for Alzheimer's Disease [ J ]. In- tern Med ,20! 1,269:54 - 63.
  • 3Bard F, Cannon C, Barbour R, et al. Peripherally adminis- tered antibodies against amyloid beta-peptide enter the cen- tral nervous system and reduce pathology in a mouse model of Alzheimer disease [ J ]. Nat Med,2000,6:916 - 919.
  • 4Carman A J, Mills JH, Krenz A, et al. Adenosine receptor signaling modulates permeability of the blood-grain barrier [ J]. J NeurolSci ,2011,31 : 13272 - 13280.
  • 5Nakane PK, Kawaoi A. Peroxidase-labeled antibody A new method of conjugation [ J ]. J Histochem Cytochem, 1974, 22 : 1084 - 1091.
  • 6Zhang Q, Liu Y, Yang N,et al. Nasal administration of CB- NGF improves the space learning and Memory abilities in AI32s_35 induced amnesic mice [ J ]. Neuroseience, 2008, 155:234 - 240.
  • 7姚晶晶,何淑蓉,陈岚,杨丽,乔旭柏,张伟,杜俊,刘冬戈.细胞因子白细胞介素-1α、S100β 在阿尔茨海默病不同类型老年斑中的表达[J].中华病理学杂志,2011,40(9):581-584. 被引量:5
  • 8Sakane T,Akizuki M,Yamashita S,et al. Direct drug trans-port from the rat nasal cavity to the cerebrospinal fluid:the relation to the molecular weight of drugs[ J]. J Pharm Phar- maeol, 1995,47:379 - 381.
  • 9Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transrnasal approach to the human brain[ J]. Nat Neurosci, 2002,5:51d - 516.
  • 10Jobling MG, Holmes RK. Mutational analysis of ganglioside GM ( 1 ) -binding ability, pentamer Formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras [ J ]. Infect immune, 2002, 70 : 1260 - 1271.

二级参考文献18

  • 1刘冬戈,何淑蓉,张伟,崔娣,Yue kui Li,W. Sue,T. Griffin.阿尔茨海默病神经细胞凋亡与小胶质细胞活化的关系[J].中华病理学杂志,2004,33(5):404-407. 被引量:17
  • 2Griffin WS,Stanley LC,Ling C,et al.Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proc Natl Acad Sci U S A,1989,86(19):7611-7615.
  • 3Xiang Z,Haroutunian Ⅴ,Ho L,et al.Microglia activation in the brain as inflammatory biomarker of Alzheimer' s disease neuropathology and clinical dementia.Dis Markers,2006,22(1-2):95-102.
  • 4Sheng JG,Mrak RE,Rovnaghi CR,et al.Human brain S100beta and S100 beta mRNA expression increases with age:pathogenic implications for Alzheimer's disease.Neurobiol Aging,1996,17(3):359-363.
  • 5Griffin WS.Inflammation and neurodegenerative diseases.Am J Clin Nutr,2006,83 (2):470S-474S.
  • 6Van Eldik LJ,Griffin WS.S100 beta expression in Alzheimer's disease:relation to neuropathology in brain regions.Biochim Biophys Acta,1994,1223(3):398-403.
  • 7Sheng JG,Mrak RE,Griffin WS.Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.Acta Neuropathol,1997,94(1):1-5.
  • 8Griffin WS,Sheng JG,Roberts GW,et al.Interleukin-1expression in different plaque types in Alzheimer's disease:significance in plaque evolution.J Neuropathol Exp Neurol,1995,54(2):276-281.
  • 9Rojo LE,Fernández JA,Maccioni AA,et al.Neuroinflammation:implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.Arch Med Res,2008,39(1):1-16.
  • 10Streit WJ,Conde JR,Harrison JK.Chemokines and Alzheimer's disease.Neurobiol Aging,2001,22(6):909-913.

共引文献6

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部